Catalyst Wire Dossier Catalyst Wire Dossier

YESINTEK

USTEKINUMAB · Biocon Biologics Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for YESINTEK, covering 2024-11-29 to 2026-08-14. Get the full timeline:

Most recent: FDA Approved: YESINTEK — Supplemental Application (Biocon Biologics Inc.)

See pricing